Chronic Fatiguing
Illnesses Research
Prof. Garth L. Nicolson
Chronic Fatigue Syndrome, Fibromyalgia Syndrome and Other Fatigue
Conditions
Chronic
fatigue is reported by 20% of all patients seeking medical care and is
considered as a nonspecific sign that is associated with many well known
medical conditions. Chronic Fatigue Syndrome (CFS), Myalgic
Encephalomyelitis (ME), and Fibromyalgia Syndrome (FMS) patients suffer
from complex overlapping signs and symptoms. (see 'Signs/Symptoms'
Questions, above) CFS is primarily characterized by persisting or
relapsing fatigue without previous history of comparable symptoms that
does not resolve with rest. In these patients other clinical conditions
are absent that can explain the signs and symptoms such as malignancies
or autoimmune diseases. In contrast, FMS patients have overall muscle
pain, tenderness, and weakness as primary complaints, but they have most
if not all of the commonly found signs and symptoms for CFS. We
previously proposed that CFS/ME patients might be suffering from chronic
infections that can cause, in part, their complex signs and symptoms.
For example, systemic mycoplasmal infections can cause chronic fatigue,
muscle pain and a variety of additional signs and symptoms, some of
which are related to dysfunctional immune responses and in extreme cases
autoimmune-like disorders. Some mycoplasmas can invade virtually every
human tissue and can compromise the immune system, permitting
opportunistic infections by other bacteria, viruses, fungi and yeast.
When mycoplasmas exit certain cells, such as synovial cells, nerve
cells, among others that can be infected, they can stimulate autoimmune
response. Our recently published studies demonstrated a possible link
between mycoplasmal infections and CFS and FMS, since we found high
frequencies of mycoplasmal infections in these patients. Previously we
examined patients with chronic illnesses for the presence of mycoplasmal
infections. We found that about one half of patients with Gulf War
Illness and two third of patients with CFS/ME and FMS were positive for
mycoplasmal infections in their blood. The Gulf War Veterans suffer from
signs and symptoms similar to patients diagnosed with CFS and FMS. They
can be treated using antibiotics effective against mycoplasmal
infections, and once they recover, their blood is no longer positive for
the presence of mycoplasmal infections. Our recent results indicate that
Rheumatoid Arthritis is also associated with mycoplasmal infections.
(see 'Autoimmune Diseases')
Recent
reports and publications indicate that in addition to mycoplasmal
infections, CFS/ME and FMS patients have other chronic infections caused
by other intracellular bacteria and viruses. For example, patients with
Lyme Disease, caused by intracellular Borrelia infections, have
been diagnosed with CFS/ME. Also, CFS/ME and FMS patients can have
intracellular Chlamydia
species infections. These patients can also have infections by other
bacteria that enter their bodies through 'leaky gut' problems.
Chronically ill patients often have inflammatory bowel syndrome and
other gut problems, and this can allow pathogenic bacteria to enter
their systems.
Patients
with CFS/ME and FMS can also have viral infections that complicate their
conditions and cause morbidity. Such infections can occur with or
without the bacterial infections described above. Viruses that have been
associated with CFS/ME and FMS are Human Herpes Virus-6 (HHV-6) and
Cytomeglovirus (CMV). These viruses have been found at high incidence in
chronically ill patients, and especially those with CFS/ME. Patients
with CFS/ME or FMS can have predominantly intracellular bacterial
infections, predominantly viral infections, or a combination of
intracellular bacterial and viral infections. This may be one reason why
the underlying causes of these chronic illnesses are so difficult to
determine and effectively treat. The other reason could be the
persistent nature of the infections and their ability to hide inside
cells where they are essentially refractory to immune system responses,
their slow growing natures and their relative insensitivity to
therapeutic drugs (see references below).
A new direction at the Institute is
studying the role of decreased cellular energy in causing fatigue.
Cellular energy is mainly produced by the mitochondria, subcellular
organelles that contain the machinery that converts fats and sugars to
energy in the form of the high-energy molecules, such as ATP.
Mitochondrial function requires an intact inner membrane where the
electron transport chain or energy machinery is located. When the
inner mitochondrial membrane is damaged, the efficiency of the electron
transport chain is reduced along with the ability of cells to produce
the energy that they need for vital functions—thus fatigue becomes a
problem. Various environmental insults and even aging
produce excess oxidation molecules that can damage the mitochondrial
membrane, including chronic infections of the type mentioned above.
At the Institute for Molecular Medicine clinical studies have shown the
benefits of dietary membrane lipids (Lipid Replacement Therapy) in
replacing damaged mitochondrial membrane lipids, increasing the
efficiency of the electron transport chain, increasing energy and
reducing fatigue. A number of non-pharmaceutical approaches to
decreasing fatigue are being investigated at the Institute.
Publications
-
Membrane Lipid Replacement—a functional approach to repairing
cellular membranes, reducing symptoms, and restoring function,
by Nicolson GL. Functional Food Science 2022; 2(8): 198-204.
pdf_doc
-
Aging and chronic illnesses: Membrane Lipid Replacement for
restoring mitochondrial function and reducing fatigue, pain, and
other symptoms in aged individuals, by Nicolson GL, Breeding PC.
Settineri R, Ferreira de Mattos G. Bioactive Compounds in Health
& Disease 2020; 3(10): 194-203.
pdf_doc
-
Membrane Lipid Replacement: reduction of pain, fatigue,
gastrointestinal and other symptoms in patients with peripheral
pain: case reports, by Nicolson GL, Breeding P. Journal of
Healthcare & Prevention 2020; 3(2): 1-4.
pdf_doc
-
An integrative model of chronically activated immune-hormonal
pathways important in the generation of fibromyalgia, by Paul
C. Breeding, Nancy Russell and Garth L. Nicolson. Brit. J. Medical
Practitioners 2012; 5(3): a524-a534.
pdf_doc
-
Considerations When Undergoing Treatment For Gulf War
Illness/Chronic
Fatigue Syndrome, Fibromyalgia Syndrome, Rheumatoid Arthritis And
Other
Autoimmune Illnesses Reprinted from the International Journal
of Medicine
1998;
1:123-128. Supplemental Suggestions: Prof. Nicolson 1/15/11
pdf_doc
-
Mitochondrial dysfunction and chronic disease: treatement with
natural supplements, by Prof. Garth Nicolson, Alternative
Therapy in Health nd Medicine 2013; 19: e5027 [Epub ahead of
print].
pdf_doc
-
Lipid Replacement Therapy with a glycophospholid formulation with
NADH and CoQ10 significantly reduces fatigue in intractable chronic
fatiguing illnesses and chronic Lyme disease, by G.L. Nicolson,
R. Settineri, R. and R.R. Ellithorpe, International Journal of
Clinical Medicine 2012; 3(3): 163-170,
pdf_doc
-
An integrative model of chronically activated immune-hormonal
pathways important in the generation of fibromyalgia, by P.C.
Breeding, N.C. Russell and G.L. Nicolson, British Journal of
Medical Practitioners 2012; 5(3): a524-a534.
pdf_doc
-
Lipid Replacement Therapy Drink Containing a Glycophospholipid
Formulation
Rapidly and Significantly Reduces Fatigue While Improving Energy and
Mental Clarity, by R. Ellithorpe, R. Settineri, C. Mitchell,
B. Jacques,
E. Ellithorpe, and G. L. Nicolson, Functional Foods in Health and
Disease,
2011; 8: 245-254.
pdf_doc
-
Chronic Fatigue Syndrome Patients
Subsequently Diagnosed with Lyme Disease Borrelia burgdorferi:
Evidence for Mycoplasma species Co-Infections - by Garth L.
Nicolson, PhD, Nancy L. Nicolson, PhD and Joerg Haier, MD, PD,
Journal of Chronic Fatigue Syndrome 2008; 14(4):5-17. -
pdf doc
-
Metabolic Syndrome and Mitochondrial Function: Molecular
Replacement and Antioxidant Supplements to Prevent Membrane
Peroxidation and Restore Mitochondrial Function, Garth L.
Nicolson, Journal of Cellular Biochemistry 2007; 100: 1352-1359.
pdf doc
-
Lipid replacement and antioxidant nutritional
therapy for restoring mitochondrial function and reducing fatigue in
chronic fatigue syndrome and other fatiguing illnesses,
by Nicolson and Ellithorpe, Journal of Chronic Fatigue Syndrome
2006; 13(1): 57-68.
pdf doc
-
Evidence for
Brucella spp. And Mycoplasma ssp. Co-Infections in
Blood of Fatigue Syndrome Patients, by Nicolson et al.,
Journal of Chronic Fatigue Syndrome 2005; 12(2): 5-17.
pdf doc
-
Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6)
in blood of chronic fatigue syndrome patients: association with
signs and symptoms. By G. L. Nicolson et al., Acta Pathol.
Microbiol. Immunol. Scand.(APMIS) 2003; 111: 557-566.
pdf doc
-
Evidence for Bacterial (Mycoplasma,
Chlamydia) and Viral (HHV-6) Co-Infections in Chronic Fatigue
Syndrome Patients by G.L. Nicolson et al., Journal of
Chronic Fatigue Syndrome 2003; 11(2):7-20.
pdf doc
-
High
Prevalence of Mycoplasma infections among European Chronic
Fatigue Syndrome patients. By J. Nijs et al., FEMS Immunol.
Med. Microbiol. 2002; 34:209-214.
pdf doc
-
Diagnosis and integrative treatment of
intracellular bacterial infections in Chronic Fatigue and
Fibromyalgia Syndromes, Gulf War Illness, Rheumatoid Arthritis and
other chronic illnesses. by G.L. Nicolson et al., Clin.
Pract. Alt. Medicine 2000; 1(2): 92-102
pdf doc
-
Role of Mycoplasmal Infections in
Fatigue Illnesses: Chronic Fatigue and Fibromyalgia Syndromes, Gulf
War Illness and Rheumatoid Arthritis, by G.L. Nicolson et
al., J. Chronic Fatigue Syndr. 2000; 6(3/4):23-39
pdf doc
-
Identification And Treatment Of Chronic
Infections In CFIDS, Fibromyalgia Syndrome And Rheumatoid Arthritis,
by G.L. Nicolson, CFIDS Chronicle 1999; 12(3): 19-21
pdf doc
-
Multiple Mycoplasmal Infections
Detected in Blood of Chronic Fatigue Syndrome and Fibromyalgia
Syndrome Patients, Eur. J. Clin. Microbiol. Infect. Dis. 1999
; 18 : 859-865
pdf doc
-
Mycoplasmal Infections in Chronic
Illnesses: Fibromyalgia and Chronic Fatigue Syndromes, Gulf War
Illness, HIV-AIDS and Rheumatoid Arthritis,
by G.L. Nicolson
et al., Med. Sentinel 1999; 4: 172-176
pdf doc
-
The Pathogenesis and Treatment of
Mycoplasmal Infections, by G.L. Nicolson et al., Antimicrob.
Infect. Dis. Newsl. 1999; 17(11) : 81-88
pdf doc
*PDF files can be opened by
obtaining a free copy of Adobe Acrobat from:
http://www.adobe.com/products/acrobat/readstep2.html
Reports
-
Fatigue, Immunity and Inflammation: their resolution using
natural medicine, by M. Ash, R. Settineri and G.L. Nicolson.
Townsend Letter 2012; 352(10): 48-51.
pdf_doc
-
Finally an answer to the most common medical complaint—Fatigue,
by Garth
L. Nicolson Public Health Alert 10(10): 1-5 (2011).
pdf_doc
-
Mycoplasmas: the Missing Link in
Fatiguing Illnesses by Michael Guthrie Alternative Medicine;
2001; Sept: 60-70.
rtf doc
-
Research Overview: Professor Garth
Nicolson's Studies and Treatments Explained By Deborah
Cooper, ImmuneSupport.com Treatment & Research Library
rtf doc
-
CFS National Radio Program 11/21/00
with Dr. Roger G. Mazlen interviewing Prof. Garth Nicolson
rtf doc
-
The Role of Chronic Infections in the
Maintenance and Progression of Chronic Fatigue Syndrome,
Fibromyalgia Syndrome, Rheumatoid Arthritis, Immune Deficiency
Syndromes and Gulf War Illness, by G.L. Nicolson et al.,
ME/CFS Congress, Sydney, Australia, 1999
rtf doc
-
Identification and Treatment of Chronic
Infections in CFIDS, Fibromyalgia Sydrome and Rheumatoid Arthritis
Patients that Cause Morbidity and Illness Progression, by
Prof. Garth Nicolson, Doctor's Educational Booklet, CFIDS Assoc. of
America, 1998
rtf doc
*PDF files can be opened by
obtaining a free copy of Adobe Acrobat from:
http://www.adobe.com/products/acrobat/readstep2.html
|
|